339 related articles for article (PubMed ID: 21106988)
1. Assessing the potential for AAV vector genotoxicity in a murine model.
Li H; Malani N; Hamilton SR; Schlachterman A; Bussadori G; Edmonson SE; Shah R; Arruda VR; Mingozzi F; Wright JF; Bushman FD; High KA
Blood; 2011 Mar; 117(12):3311-9. PubMed ID: 21106988
[TBL] [Abstract][Full Text] [Related]
2. A largely random AAV integration profile after LPLD gene therapy.
Kaeppel C; Beattie SG; Fronza R; van Logtenstein R; Salmon F; Schmidt S; Wolf S; Nowrouzi A; Glimm H; von Kalle C; Petry H; Gaudet D; Schmidt M
Nat Med; 2013 Jul; 19(7):889-91. PubMed ID: 23770691
[TBL] [Abstract][Full Text] [Related]
3. AAV vector integration sites in mouse hepatocellular carcinoma.
Donsante A; Miller DG; Li Y; Vogler C; Brunt EM; Russell DW; Sands MS
Science; 2007 Jul; 317(5837):477. PubMed ID: 17656716
[TBL] [Abstract][Full Text] [Related]
4. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Rosas LE; Grieves JL; Zaraspe K; La Perle KM; Fu H; McCarty DM
Mol Ther; 2012 Nov; 20(11):2098-110. PubMed ID: 22990674
[TBL] [Abstract][Full Text] [Related]
5. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
Chandler RJ; LaFave MC; Varshney GK; Trivedi NS; Carrillo-Carrasco N; Senac JS; Wu W; Hoffmann V; Elkahloun AG; Burgess SM; Venditti CP
J Clin Invest; 2015 Feb; 125(2):870-80. PubMed ID: 25607839
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
7. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
George LA; Ragni MV; Rasko JEJ; Raffini LJ; Samelson-Jones BJ; Ozelo M; Hazbon M; Runowski AR; Wellman JA; Wachtel K; Chen Y; Anguela XM; Kuranda K; Mingozzi F; High KA
Mol Ther; 2020 Sep; 28(9):2073-2082. PubMed ID: 32559433
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.
Hadi M; Qutaiba B Allela O; Jabari M; Jasoor AM; Naderloo O; Yasamineh S; Gholizadeh O; Kalantari L
Virol J; 2024 Jan; 21(1):17. PubMed ID: 38216938
[TBL] [Abstract][Full Text] [Related]
10. No evidence for tumorigenesis of AAV vectors in a large-scale study in mice.
Bell P; Wang L; Lebherz C; Flieder DB; Bove MS; Wu D; Gao GP; Wilson JM; Wivel NA
Mol Ther; 2005 Aug; 12(2):299-306. PubMed ID: 16043099
[TBL] [Abstract][Full Text] [Related]
11. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
12. [Integration of AAV vectors and insertional mutagenesis].
Rossi A; Salvetti A
Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
[TBL] [Abstract][Full Text] [Related]
13. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.
Nakai H; Wu X; Fuess S; Storm TA; Munroe D; Montini E; Burgess SM; Grompe M; Kay MA
J Virol; 2005 Mar; 79(6):3606-14. PubMed ID: 15731255
[TBL] [Abstract][Full Text] [Related]
14. Integration and the risk of liver cancer-Is there a real risk?
Kasimsetty A; Sabatino DE
J Viral Hepat; 2024 Apr; 31 Suppl 1():26-34. PubMed ID: 38606944
[TBL] [Abstract][Full Text] [Related]
15. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
16. The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis.
Nowrouzi A; Cheung WT; Li T; Zhang X; Arens A; Paruzynski A; Waddington SN; Osejindu E; Reja S; von Kalle C; Wang Y; Al-Allaf F; Gregory L; Themis M; Holder M; Dighe N; Ruthe A; Buckley SM; Bigger B; Montini E; Thrasher AJ; Andrews R; Roberts TP; Newbold RF; Coutelle C; Schmidt M; Themis M
Mol Ther; 2013 Feb; 21(2):324-37. PubMed ID: 23299800
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy vectors based on adeno-associated virus type 1.
Xiao W; Chirmule N; Berta SC; McCullough B; Gao G; Wilson JM
J Virol; 1999 May; 73(5):3994-4003. PubMed ID: 10196295
[TBL] [Abstract][Full Text] [Related]
18. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
19. A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery.
Huang YH; Fang CC; Tsuneyama K; Chou HY; Pan WY; Shih YM; Wu PY; Chen Y; Leung PS; Gershwin ME; Tao MH
Int J Oncol; 2011 Dec; 39(6):1511-9. PubMed ID: 21805030
[TBL] [Abstract][Full Text] [Related]
20. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver.
Bell P; Moscioni AD; McCarter RJ; Wu D; Gao G; Hoang A; Sanmiguel JC; Sun X; Wivel NA; Raper SE; Furth EE; Batshaw ML; Wilson JM
Mol Ther; 2006 Jul; 14(1):34-44. PubMed ID: 16682254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
